Clinical trials
Phase 3 Triple Negative Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
90 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 8 |
| 2021 | 3 |
| 2022 | 7 |
| 2023 | 7 |
| 2024 | 8 |
| 2025 | 8 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 24 |
| Completed | 23 |
| Active, not recruiting | 19 |
| Not yet recruiting | 9 |
| Unknown status | 7 |
| Terminated | 5 |
| Suspended | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 15 |
| Hoffmann-La Roche | 7 |
| Merck Sharp & Dohme LLC | 6 |
| Chinese Academy of Medical Sciences | 3 |
| Gilead Sciences | 3 |
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 3 |
| UNICANCER | 3 |
| Jiangsu HengRui Medicine Co., Ltd. | 2 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 2 |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 90 |
| Breast Neoplasms | 33 |
| Neoplasm Metastasis | 3 |
| Neoplasms | 3 |
| Basal Cell Carcinoma | 1 |
| Brain Neoplasms | 1 |
| Breast Carcinoma In Situ | 1 |
| Breast Diseases | 1 |
| Carcinoma, Ductal, Breast | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 1 to 25 of 90. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.